Fukuda Nobuhisa, Sasaki Kazuki, Sastry T V R S, Kanai Motomu, Shibasaki Masakatsu
Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033.
J Org Chem. 2006 Feb 3;71(3):1220-5. doi: 10.1021/jo0524223.
Total synthesis of (+)-lactacystin, a potent and selective proteasome inhibitor, was accomplished using a catalytic enantioselective Strecker reaction of a ketoimine as the initial key step. An enone-derived N-phosphinoyl ketoimine 7 was selected as a stable masked alpha-hydroxy ketoimine analogue. Excellent enantioselectivity (98% ee) and practical catalyst activity were produced under the optimized catalyst preparation method using 2.5 mol % Gd{N(SiMe3)2}3 as a metal source and 3.8 mol % D-glucose-derived ligand 8. This reaction was conducted on a 5 g scale. The chiral tetrasubstituted C-5 carbon efficiently controlled the stereochemistry of the other three chiral centers of lactacystin. Chelation-controlled Meerwein-type reduction of ketone 5 using i-PrMgBr (originally reported by Kang in a related substrate) selectively produced the desired secondary alcohol at the C-9 position. The C-6 hydroxy and C-7 methyl groups were introduced via a silyl conjugate addition followed by the Tamao oxidation and Donohoe methylation, respectively, in a highly stereoselective manner. A practical amount of enantiomerically pure clasto-lactacystin beta-lactone (2), the biologically active form of (+)-lactacystin, can be synthesized using this route. clasto-Lactacystin beta-lactone (2) was converted to (+)-lactacystin following the reported procedure.
强效选择性蛋白酶体抑制剂(+)-乳胞素的全合成,是以酮亚胺的催化对映选择性斯特雷克反应作为起始关键步骤完成的。选择烯酮衍生的N-膦酰基酮亚胺7作为稳定的掩蔽α-羟基酮亚胺类似物。在优化的催化剂制备方法下,以2.5 mol%的Gd{N(SiMe3)2}3作为金属源和3.8 mol%的D-葡萄糖衍生配体8,产生了优异的对映选择性(98% ee)和实用的催化剂活性。该反应以5 g规模进行。手性四取代的C-5碳有效地控制了乳胞素其他三个手性中心的立体化学。使用异丙基溴化镁(最初由Kang在相关底物中报道)对酮5进行螯合控制的迈尔温型还原,在C-9位选择性地生成了所需的仲醇。C-6羟基和C-7甲基分别通过硅烷基共轭加成,随后进行玉尾氧化和多诺霍甲基化,以高度立体选择性的方式引入。使用该路线可以合成实际用量的对映体纯的裂环-乳胞素β-内酯(2),即(+)-乳胞素的生物活性形式。按照报道的方法,将裂环-乳胞素β-内酯(2)转化为(+)-乳胞素。